Josh brings more than 25 years of experience serving clients and leading teams, most of which in healthcare advisory, bringing that expertise to rule of three, LLC as its CEO. He has been privileged to hold previous leadership roles at KPMG, IBM Watson Health, Dixon Hughes Goodman (now Forvis Mazars), and Citrin Cooperman. Both his current role and those past have presented opportunities to bring unconventional thinking to his clients, while supporting dynamic teams, across the full healthcare ecosystem (Providers, Plans, Employers, Governments, Advocacy, etc.). He has been published numerous times over the years, as well as quoted widely, on a variety of healthcare trends and industry-relevant issues impacting how care is delivered, coordinated and administered. Currently, he serves on the Boards of vital.io, Validation Institute, the Population Health Management Journal, and HealthTrackRx.
Some of his clients have included the Hospital Corporation of America, the Department of Health and Human Services (including the Centers for Disease Control and Prevention and the Centers for Medicare & Medicaid Services), various pediatric health systems, the National Association for Healthcare Quality, Nebraska Medicine, Penn Medicine, the Ochsner Health System/Network, the BJC Collaborative and The Leapfrog Group, as well as a variety of other healthcare organizations. He has developed longstanding client relationships at all levels of organizations, notably including some of the most prestigious C-suite executives in healthcare today.
Josh’s expertise spans both the consulting and healthcare industries. He has led businesses and engagements that include strategic planning, change management, organizational design, communications strategy, design thinking, strategic facilitation, health informatics/analytics, strategic partnerships, regulatory affairs, appropriations law, population health, policy analysis/planning, vendor selection, systems integration, clinical integration, physician alignment and care coordination, amongst others.